Publications by authors named "Thi Thanh Dinh"

Article Synopsis
  • Anaplastic lymphoma kinase (ALK) is a key target for cancer treatment, and NVP-TAE684, an ALK inhibitor, shows promise in fighting various cancers, including pancreatic adenocarcinoma.
  • In this study, NVP-TAE684 effectively reduced the growth of pancreatic cancer cells, leading to increased cell death and cell cycle arrest by disrupting the ALK signaling pathway.
  • The research also demonstrated that combining NVP-TAE684 with gemcitabine, a common chemotherapy drug, significantly enhanced the treatment's effectiveness against cancer cells.
View Article and Find Full Text PDF

Background: There are currently two markers used to monitor treatment response to anti-retroviral therapy (ART) in HIV-infected children: CD4 T-cell count and HIV viral load; but analysis of these could be challenging in resource-poor countries. The aim of this study was therefore to determine whether change in growth parameters such as weight-for-age Z score (WAZ), height-for-age Z score (HAZ) and body mass index-for-age Z score (BMIZ) is associated with treatment response in HIV-infected children.

Methods: This was a nested case-control study, in which the data were collected at enrolment and then periodically every 6 months for a total 36 month follow up of 107 HIV-infected children enrolled and treated at National Hospital of Pediatrics, Vietnam.

View Article and Find Full Text PDF

Objectives: Over the past decades, Vietnam has made great strides in reducing the rate of mortality in HIV-related deaths, due to increased access of antiretroviral therapy (ART); however, given the significantly high level of treatment failure (TF), it is essential to identify markers that describe the failure of ART in HIV-1 infected children.

Methods: A nested case-control study was conducted with clinical data collected from 101 HIV-infected children [26 TF and 75 treatment success (TS)] at National Hospital of Pediatrics, Vietnam (2008-2012).

Results: The results showed that certain factors including height, weight, vaccination with Hepatitis B, and platelet were significantly different between TF and TS before starting the treatment.

View Article and Find Full Text PDF